EDGAR Filing Documents for 0001178913-22-004096

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]

SEC Accession No. 0001178913-22-004096

Filing Date

2022-11-17

Accepted

2022-11-17 16:40:22

Documents

Group Members

KOBI GEORGE

Document Format Files

Seq	Description	Document	Type	Size
1	SC 13D/A	zk2228783.htm	SC 13D/A	56103
2	EXHIBIT 1	exhibit_1.htm	EX-99	3474
	Complete submission text file	0001178913-22-004096.txt		60989

Mailing Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002

Business Address KIRYAT ATIDIM, BUILDING 7 TEL AVIV L3 6158002 972-77-331-0156

Chemomab Therapeutics Ltd. (Subject) CIK: 0001534248 (see all company filings)

IRS No.: 813676773 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86953 | Film No.: 221398988
SIC: 2834 Pharmaceutical Preparations

Mailing Address 15 KAFRISIN ST. TEL AVIV L3 6901658

Business Address

Mor George Adi (Filed by) CIK: 0001851069 (see all company filings)

Type: SC 13D/A